To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ITGB5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
560 supporting clones for gene ITGB5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX381162 Placenta Cot 25-normalized .a 1 to 912 1 to 911       911/911
(100 %)
3 diff
(99.7 %id)
BC006541 Kidney, renal cell adenocarcinoma .a 2 to 3372 1 to 3371 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3371/3371
(100 %)
5 diff
(99.9 %id)
NM_002213.3   .a 2 to 3372 1 to 3371 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3371/3371
(100 %)
5 diff
(99.9 %id)
AW732475 Kidney, renal cell adenocarcinoma .a 6 to 188 1 to 183       183/183
(100 %)
0 diff
(100 %id)
AL541461 placenta .a 73 to 1078 1 to 1005       1005/1005
(100 %)
10 diff
(99.1 %id)
DN996303 breast cancer, Mammary gland (cancer tissue) .a 240 to 845 9 to 614       606/614
(98 %)
0 diff
(100 %id)
BG831036 epithelioid carcinoma cell line, Pancreas .a 253 to 1076 1 to 826       826/917
(90 %)
11 diff
(98.9 %id)
J05633   .a 253 to 3368 1 to 3116 L645P     3116/3117
(99 %)
2 diff
(100.0 %id)
AK315429 brain .a 258 to 2698 1 to 2441 R431Q     2441/2441
(100 %)
6 diff
(99.8 %id)
DA495975 brain .a 259 to 803 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
AU132552   .a 267 to 1051 2 to 787   capped   786/786
(100 %)
8 diff
(99.0 %id)
BX396260 Placenta Cot 25-normalized .a 284 to 1272 1 to 987       987/987
(100 %)
2 diff
(99.8 %id)
DA436295 tongue, tumor tissue .a 297 to 844 2 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
DA581332 lung .a 340 to 852 2 to 518   capped   517/517
(100 %)
4 diff
(99.3 %id)
CV027549 mixed .a 371 to 732 73 to 434       363/434
(83 %)
45 diff
(89.7 %id)
DA747086   .a 381 to 940 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
TI_154195119   .a 387 to 1420 45 to 1067       1023/1066
(95 %)
32 diff
(97.0 %id)
BE315315 adenocarcinoma cell line, ovary .a 406 to 1075 1 to 667       667/699
(95 %)
12 diff
(98.3 %id)
TI_154198036   .a 441 to 1194 100 to 850       751/918
(81 %)
13 diff
(98.6 %id)
TI_154197195   .a 447 to 1289 69 to 909       841/1003
(83 %)
13 diff
(98.8 %id)
BG746469 adenocarcinoma cell line, colon .a 448 to 1142 2 to 696       695/696
(99 %)
10 diff
(98.6 %id)
TI_154196404   .a 453 to 1314 27 to 881       856/1084
(78 %)
22 diff
(98.0 %id)
TI_154196811   .a 453 to 1334 22 to 897       877/1090
(80 %)
33 diff
(97.0 %id)
CO248685 Chondrosarcoma Lung Metastasis cell lines, lung .a 454 to 1171 8 to 716       709/832
(85 %)
21 diff
(97.5 %id)
CB128712 Liver .a 458 to 1059 1 to 602       602/602
(100 %)
0 diff
(100 %id)
ES315308 occipital scalp hair, skin .a 465 to 634 1 to 170       170/170
(100 %)
1 diff
(99.5 %id)
CF125152 Chondrosarcoma Lung Metastasis cell lines, lung .a 477 to 1053 1 to 578       578/578
(100 %)
5 diff
(99.2 %id)
TI_154186665   .a 481 to 1232 51 to 798       748/799
(93 %)
14 diff
(98.3 %id)
DA311930 hippocampus .a 507 to 1044 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
CO247398 Chondrosarcoma Lung Metastasis cell lines, lung .a 524 to 1181 1 to 652       652/808
(80 %)
15 diff
(98.2 %id)
CO248079 Chondrosarcoma Lung Metastasis cell lines, lung .a 525 to 1241 1 to 714       714/752
(94 %)
17 diff
(97.8 %id)
BG248223 adenocarcinoma cell line, colon .a 527 to 1242 1 to 707       707/901
(78 %)
21 diff
(97.7 %id)
CN265300 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 551 to 1264 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
TI_154195916   .a 552 to 1535 14 to 986       973/1094
(88 %)
48 diff
(95.7 %id)
CO394538 Chondrosarcoma Lung Metastasis cell lines, lung .a 555 to 1286 1 to 728       728/729
(99 %)
16 diff
(97.9 %id)
TI_154197548   .a 562 to 1398 91 to 913       823/961
(85 %)
31 diff
(96.8 %id)
BQ278978 adenocarcinoma, cell line, breast .a 568 to 1433 1 to 870       870/1001
(86 %)
11 diff
(99.0 %id)
BG325638 Kidney, renal cell adenocarcinoma .a 575 to 1241 1 to 662       662/880
(75 %)
6 diff
(99.4 %id)
BE273024 Kidney, renal cell adenocarcinoma .a 596 to 1227 1 to 627       627/698
(89 %)
14 diff
(98.0 %id)
BJ994457 hepatoblastoma .a 617 to 1038 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BX482120   .a 622 to 1007 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BG328621 adenocarcinoma cell line, colon .a 659 to 1381 16 to 735       723/735
(98 %)
14 diff
(98.1 %id)
CD614240   .a 661 to 801 157 to 18       140/157
(89 %)
0 diff
(100 %id)
BG747991 eye, normal pigmented retinal epithelium .a 661 to 1358 1 to 696       696/696
(100 %)
7 diff
(99.0 %id)
DA033937   .a 664 to 1241 2 to 581   capped   580/582
(99 %)
3 diff
(99.5 %id)
BF767298 colon_normal .a 678 to 1079 422 to 23     Submitted on the opposite strand 400/422
(94 %)
3 diff
(99.3 %id)
CN265302 embryonic stem cells, cell lines H1, H7, andH9 .a 678 to 1176 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BG830956 epithelioid carcinoma cell line, Pancreas .a 689 to 1389 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
BF767296 colon_normal .a 692 to 1079 411 to 24     Submitted on the opposite strand 388/411
(94 %)
1 diff
(99.8 %id)
BX327923 Placenta Cot 25-normalized .a 695 to 1426 1 to 737       737/737
(100 %)
15 diff
(98.0 %id)
BX327922 Placenta Cot 25-normalized .a 698 to 1336 1 to 646       646/740
(87 %)
55 diff
(92.6 %id)
BQ326296 colon_normal .a 712 to 1071 359 to 1       359/359
(100 %)
10 diff
(97.3 %id)
DA658231   .a 720 to 1287 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_154197671   .a 747 to 1766 98 to 1102       1005/1005
(100 %)
27 diff
(97.4 %id)
CO245749 Chondrosarcoma Lung Metastasis cell lines, lung .a 777 to 1520 8 to 739       732/823
(88 %)
23 diff
(97.3 %id)
CO245870 Chondrosarcoma Lung Metastasis cell lines, lung .a 781 to 1424 1 to 643       643/807
(79 %)
5 diff
(99.4 %id)
BG249026 hypernephroma, cell line, Kidney .a 784 to 1536 1 to 751       749/764
(98 %)
16 diff
(98.0 %id)
CB151690 cervix, Uterine .a 785 to 1357 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DA264947 caudate nucleus .a 786 to 1363 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA047813   .a 789 to 1327 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BE512877 adenocarcinoma cell line, colon .a 823 to 1410 1 to 588       588/591
(99 %)
2 diff
(99.7 %id)
BX478266   .a 828 to 1429 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
DA159719 amygdala .a 846 to 1404 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB060920 testis .a 848 to 1375 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
AW796588 uterus .a 855 to 1203 365 to 16       350/365
(95 %)
1 diff
(99.8 %id)
DA997548   .a 872 to 1438 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BU160319 melanotic melanoma, skin .a 873 to 1667 1 to 804       804/822
(97 %)
12 diff
(98.6 %id)
BQ331562 lung_tumor .a 881 to 1372 513 to 21       493/647
(76 %)
8 diff
(98.8 %id)
DA602466   .a 892 to 1467 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BI043878 ovary .a 913 to 1163 247 to 1       247/247
(100 %)
10 diff
(96.0 %id)
DA635636 Kidney .a 918 to 1492 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BP241998 Liver .a 920 to 1495 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BQ962979 epithelioid carcinoma cell line, Pancreas .a 926 to 1794 1 to 881       881/886
(99 %)
20 diff
(97.8 %id)
DB189023 liver, tumor tissue .a 933 to 1518 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
CX784241 human embryonic stem cells .a 942 to 1625 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
CF125697 Chondrosarcoma Lung Metastasis cell lines, lung .a 951 to 1584 1 to 634       634/634
(100 %)
0 diff
(100 %id)
TI_154186532   .a 951 to 1701 44 to 794       751/751
(100 %)
3 diff
(99.7 %id)
AL543371 placenta, Placenta Cot 25-normalized .a 964 to 1983 1 to 1012       1012/1019
(99 %)
12 diff
(98.9 %id)
BG010489 placenta_normal .a 973 to 1142 28 to 201       174/202
(86 %)
15 diff
(92.6 %id)
BG008511 placenta_normal .a 975 to 1241 313 to 49       265/313
(84 %)
0 diff
(100 %id)
DA052567   .a 991 to 1531 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
CF131340 Chondrosarcoma Lung Metastasis cell lines, lung .a 1001 to 1747 1 to 745       745/745
(100 %)
2 diff
(99.8 %id)
TI_159676421   .a 1001 to 1968 44 to 990       947/1023
(92 %)
28 diff
(97.3 %id)
BG773909 choriocarcinoma, placenta .a 1016 to 1669 1 to 653       653/653
(100 %)
6 diff
(99.1 %id)
DA547133   .a 1038 to 1612 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BE278149 choriocarcinoma, placenta .a 1039 to 1580 1 to 542       542/544
(99 %)
3 diff
(99.5 %id)
DB057637 testis .a 1046 to 1578 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA599830   .a 1047 to 1612 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA443894 tongue, tumor tissue .a 1061 to 1644 5 to 588   capped   584/587
(99 %)
0 diff
(100 %id)
BE740642 adenocarcinoma cell line, ovary .a 1069 to 1865 1 to 792       792/858
(92 %)
10 diff
(98.9 %id)
DA378050 thalamus .a 1070 to 1601 11 to 543   capped   533/542
(98 %)
7 diff
(98.8 %id)
DA576823   .a 1072 to 1634 3 to 565   capped   563/564
(99 %)
0 diff
(100 %id)
BU172852 melanotic melanoma, skin .a 1072 to 1905 1 to 845       845/917
(92 %)
37 diff
(96.0 %id)
BE746507 adenocarcinoma cell line, ovary .a 1073 to 1869 1 to 792       795/802
(99 %)
38 diff
(95.3 %id)
DA871461 Prostate .a 1085 to 1616 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA811688 brain .a 1125 to 1687 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA658261   .a 1126 to 1689 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA713977   .a 1134 to 1701 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BP300743   .a 1136 to 1716 1 to 581       581/582
(99 %)
1 diff
(99.9 %id)
CD517656 White Matter .a 1161 to 1992 1 to 833       833/833
(100 %)
6 diff
(99.3 %id)
CD558839 White Matter .a 1161 to 1986 1 to 832       832/853
(97 %)
11 diff
(98.8 %id)
DB170465 kidney, tumor tissue .a 1162 to 1743 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB244583 uterus, tumor tissue .a 1166 to 1716 2 to 553   capped   552/554
(99 %)
2 diff
(99.7 %id)
BX417104 placenta .a 1187 to 2208 1 to 1018       1018/1022
(99 %)
14 diff
(98.7 %id)
TI_154198088   .a 1190 to 1721 62 to 592       531/921
(57 %)
36 diff
(96.1 %id)
TI_154196457   .a 1196 to 1990 28 to 820       793/1049
(75 %)
17 diff
(98.4 %id)
BE314327 brain, neuroblastoma .a 1243 to 1853 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
CX753421 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1245 to 1943 1 to 699     Submitted on the opposite strand 699/699
(100 %)
1 diff
(99.9 %id)
BG832026 epithelioid carcinoma cell line, Pancreas .a 1252 to 2097 1 to 846       846/880
(96 %)
18 diff
(98.0 %id)
EC492390 Prostate .a 1256 to 1356 97 to 1       97/97
(100 %)
4 diff
(95.9 %id)
BQ645691 hepatocellular carcinoma, cell line, Liver .a 1264 to 1992 1 to 732       732/926
(79 %)
22 diff
(97.7 %id)
TI_154197311   .a 1275 to 1876 11 to 616       606/1027
(59 %)
42 diff
(96.0 %id)
CF619433 Pooled Chondrosarcoma Tumor cells .a 1277 to 2058 1 to 790       788/873
(90 %)
15 diff
(98.3 %id)
TI_154196927   .a 1284 to 1990 23 to 728       706/1102
(64 %)
16 diff
(98.6 %id)
TI_154195679   .a 1287 to 1992 12 to 717       706/1044
(67 %)
19 diff
(98.2 %id)
BP269273 thyroid .a 1300 to 1881 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG679228 skin, squamous cell carcinoma .a 1311 to 2094 1 to 784       784/785
(99 %)
1 diff
(99.9 %id)
DA990379 synovial membrane tissue from rheumatioidarthritis .a 1322 to 1853 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BG746446 adenocarcinoma cell line, colon .a 1367 to 2072 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
TI_159678114   .a 1369 to 2271 50 to 945       899/1095
(82 %)
14 diff
(98.8 %id)
CF132259 Chondrosarcoma Lung Metastasis cell lines, lung .a 1370 to 2086 1 to 717       717/717
(100 %)
0 diff
(100 %id)
BE894159 melanotic melanoma, skin .a 1372 to 1992 1 to 622       622/1152
(53 %)
5 diff
(99.6 %id)
DA959946 Spleen .a 1377 to 1929 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BE063255 breast .a 1384 to 1585 278 to 77     Submitted on the opposite strand 202/278
(72 %)
0 diff
(100 %id)
CR609293 Placenta Cot 25-normalized .a 1385 to 3121 1 to 1737   tiling clone,   1737/1737
(100 %)
0 diff
(100 %id)
BX377565 Placenta Cot 25-normalized .a 1385 to 2245 1 to 861   fully sequenced,   861/861
(100 %)
3 diff
(99.7 %id)
BP243426 Liver .a 1386 to 1971 1 to 586       586/586
(100 %)
3 diff
(99.5 %id)
BP368420 thymus .a 1390 to 1969 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA741757   .a 1393 to 1914 2 to 524   capped   523/523
(100 %)
5 diff
(99.1 %id)
BM839434 Ascites, stomach .a 1400 to 1907 1 to 508       508/508
(100 %)
5 diff
(99.1 %id)
DA982816 synovial membrane tissue from rheumatioidarthritis .a 1416 to 1970 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
CN265298 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1420 to 2183 8 to 771       764/771
(99 %)
0 diff
(100 %id)
DN602316 human embryonic stem cells .a 1421 to 2282 14 to 875       864/876
(98 %)
88 diff
(90.0 %id)
DB003183 breast, tumor tissue .a 1422 to 1965 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
AU279907   .a 1423 to 1987 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DA377987 thalamus .a 1424 to 2053 2 to 631   capped   630/630
(100 %)
2 diff
(99.7 %id)
CX781959 human embryonic stem cells .a 1424 to 2276 1 to 853       853/853
(100 %)
1 diff
(99.9 %id)
BE258554 eye, retinoblastoma .a 1456 to 2073 1 to 618       618/618
(100 %)
5 diff
(99.2 %id)
BQ710245 Spleen .a 1458 to 2319 1 to 864       864/954
(90 %)
15 diff
(98.5 %id)
CF780846 Pooled Chondrosarcoma Tumor cells .a 1478 to 2134 62 to 725       664/1307
(50 %)
27 diff
(98.0 %id)
AW376479 colon .a 1481 to 1948 468 to 1       468/468
(100 %)
0 diff
(100 %id)
BG470267 adenocarcinoma cell line, colon .a 1492 to 2296 1 to 806       806/808
(99 %)
13 diff
(98.4 %id)
BG386501 adenocarcinoma cell line, colon .a 1500 to 2116 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
CX785309 human embryonic stem cells .a 1503 to 2328 1 to 826       826/826
(100 %)
1 diff
(99.9 %id)
BE018896 Kidney, renal cell adenocarcinoma .a 1517 to 2173 1 to 657     Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 657/657
(100 %)
6 diff
(99.1 %id)
BY798134 eye .a 1542 to 2179 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BP253749 Kidney .a 1542 to 2122 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BX333179 Neuroblastoma Cot 25-normalized .a 1562 to 2430 1 to 867       867/867
(100 %)
19 diff
(97.9 %id)
C06414   .a 1599 to 1908 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BE904131 epithelioid carcinoma, Pancreas .a 1611 to 2315 1 to 697       697/950
(73 %)
17 diff
(98.3 %id)
BG760934 melanotic melanoma, high MDR (cell line), skin .a 1632 to 2471 1 to 842       842/843
(99 %)
17 diff
(98.0 %id)
TI_57188454   .a 1645 to 2396 49 to 796       748/749
(99 %)
11 diff
(98.6 %id)
BI856511 breast, mammary adenocarcinoma, cell line .a 1646 to 2396 1 to 747       747/748
(99 %)
11 diff
(98.6 %id)
CA454404   .a 1646 to 2440 1 to 798       798/951
(83 %)
20 diff
(97.9 %id)
BE273414 Kidney, renal cell adenocarcinoma .a 1689 to 2590 1 to 899       899/909
(98 %)
41 diff
(95.5 %id)
BF204513 muscle, rhabdomyosarcoma .a 1756 to 2413 1 to 657       657/660
(99 %)
4 diff
(99.4 %id)
TI_1948150773   .a 1767 to 2214 137 to 586       450/1429
(31 %)
15 diff
(99.0 %id)
TI_1948150774   .a 1767 to 2514 130 to 893       764/1327
(57 %)
47 diff
(96.5 %id)
TI_1948151041   .a 1767 to 2443 137 to 814       678/1311
(51 %)
16 diff
(98.8 %id)
BG482060 choriocarcinoma, placenta .a 1807 to 2693 1 to 897       897/897
(100 %)
23 diff
(97.5 %id)
AL048422 uterus .a 1810 to 2454 1 to 649       649/651
(99 %)
11 diff
(98.4 %id)
BP381274 adipose tissue .a 1817 to 2435 1 to 619       619/620
(99 %)
6 diff
(99.1 %id)
BE271443 adenocarcinoma cell line, ovary .a 1830 to 2561 1 to 736       734/782
(93 %)
31 diff
(96.1 %id)
CX784257 human embryonic stem cells .a 1846 to 2427 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BI768532 pooled lung and spleen .a 1856 to 2771 1 to 920       890/987
(90 %)
30 diff
(97.0 %id)
TI_57181027   .a 1856 to 2771 69 to 988       890/1055
(84 %)
36 diff
(96.6 %id)
CU446127 epidermis .a 1875 to 2071 204 to 6     Submitted on the opposite strand 199/216
(92 %)
2 diff
(99.1 %id)
DR000464 fetal brain .a 1884 to 2388 1 to 502       502/502
(100 %)
5 diff
(99.1 %id)
TI_154186921   .a 1894 to 2838 43 to 982       940/1039
(90 %)
17 diff
(98.4 %id)
CF125786 Chondrosarcoma Lung Metastasis cell lines, lung .a 1895 to 2570 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
BF836127 head_neck .a 1903 to 2049 161 to 18     Submitted on the opposite strand 144/161
(89 %)
1 diff
(99.4 %id)
CO245699 Chondrosarcoma Lung Metastasis cell lines, lung .a 1919 to 2571 35 to 682       648/777
(83 %)
12 diff
(98.5 %id)
BP344142 synovial membrane .a 1919 to 2494 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
BG676140 skin, squamous cell carcinoma .a 1939 to 2636 1 to 695       695/696
(99 %)
6 diff
(99.2 %id)
BG109360 Bone, osteosarcoma, cell line .a 1942 to 2643 1 to 704       704/704
(100 %)
9 diff
(98.8 %id)
BG742703 skin .a 1948 to 2812 1 to 871       871/873
(99 %)
13 diff
(98.6 %id)
CF125150 Chondrosarcoma Lung Metastasis cell lines, lung .a 1948 to 2582 1 to 635       635/635
(100 %)
7 diff
(98.9 %id)
TI_154186663   .a 1948 to 2693 44 to 789       746/747
(99 %)
16 diff
(97.9 %id)
CA454186   .a 1958 to 2803 1 to 854       854/854
(100 %)
11 diff
(98.8 %id)
CD515457 White Matter .a 1958 to 2690 1 to 737       737/816
(90 %)
5 diff
(99.4 %id)
BG675840 skin, squamous cell carcinoma .a 1982 to 2812 1 to 828       828/831
(99 %)
9 diff
(99.0 %id)
TI_1948151042   .a 1983 to 2697 840 to 127       714/1327
(53 %)
11 diff
(99.2 %id)
BX350181 Placenta Cot 25-normalized .a 1990 to 2818 830 to 1       830/830
(100 %)
9 diff
(99.0 %id)
BX350182 Placenta Cot 25-normalized .a 1990 to 2818 828 to 1       828/828
(100 %)
4 diff
(99.6 %id)
TI_1948150775   .a 1990 to 2697 833 to 127       707/1395
(50 %)
9 diff
(99.4 %id)
TI_1948151043   .a 1990 to 2697 835 to 127       709/1485
(47 %)
19 diff
(98.8 %id)
BU789544 insulinoma, Pancreas .a 1998 to 2498 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
FN070097 breast carcinoma .a 2053 to 2113 1 to 62       62/63
(98 %)
2 diff
(96.9 %id)
BE909129 epithelioid carcinoma, Pancreas .a 2071 to 2695 1 to 624       624/624
(100 %)
2 diff
(99.7 %id)
BF983584 duodenal adenocarcinoma, cell line, small intestine .a 2072 to 2812 1 to 738       738/738
(100 %)
3 diff
(99.6 %id)
CD106935 brain, Pituitary .a 2087 to 2917 1 to 837       837/841
(99 %)
8 diff
(99.1 %id)
CA406325 adipose .a 2094 to 2584 1 to 491       491/491
(100 %)
0 diff
(100 %id)
CD518446 White Matter .a 2120 to 2957 1 to 845       845/990
(85 %)
8 diff
(99.2 %id)
TI_154195283   .a 2138 to 2809 1 to 673       673/1094
(61 %)
33 diff
(97.0 %id)
BE166709 head_neck .a 2140 to 2603 487 to 15     Submitted on the opposite strand 473/487
(97 %)
1 diff
(99.8 %id)
BG675148 skin .a 2152 to 2931 1 to 780       780/780
(100 %)
4 diff
(99.5 %id)
BP421359 small intestine .a 2176 to 2680 1 to 505     Submitted on the opposite strand 505/505
(100 %)
0 diff
(100 %id)
BX377564 Placenta Cot 25-normalized .a 2184 to 3121 936 to 1   fully sequenced,   936/936
(100 %)
7 diff
(99.3 %id)
AW368752 head_neck .a 2209 to 2535 9 to 336       332/338
(98 %)
18 diff
(94.7 %id)
CO248804 Chondrosarcoma Lung Metastasis cell lines, lung .a 2216 to 2911 41 to 728       688/779
(88 %)
22 diff
(97.2 %id)
H97449 melanocyte .a 2220 to 2569 1 to 353       353/361
(97 %)
10 diff
(97.3 %id)
H53214 liver and spleen .a 2223 to 2546 1 to 327       327/327
(100 %)
7 diff
(97.9 %id)
CF128485 Chondrosarcoma Lung Metastasis cell lines, lung .a 2224 to 2877 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
TI_154194377   .a 2224 to 3149 51 to 966       916/1046
(87 %)
41 diff
(96.1 %id)
AL569910 placenta, Placenta Cot 25-normalized .a 2239 to 3292 1060 to 21       1040/1060
(98 %)
17 diff
(98.4 %id)
FN077401 breast carcinoma .a 2243 to 2312 1 to 71       71/72
(98 %)
2 diff
(97.3 %id)
DW413785 Liver .a 2246 to 2556 8 to 318       311/318
(97 %)
7 diff
(97.8 %id)
ES311394 frontal balding hair, skin .a 2248 to 2429 1 to 182       182/182
(100 %)
0 diff
(100 %id)
TI_154126076   .a 2249 to 3157 982 to 87   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 896/969
(92 %)
13 diff
(98.7 %id)
N57442 placenta .a 2256 to 2806 1 to 549       549/549
(100 %)
11 diff
(98.0 %id)
R02466 liver and spleen .a 2259 to 2516 1 to 261       261/263
(99 %)
5 diff
(98.1 %id)
BQ216889 large cell carcinoma, lung .a 2261 to 3132 1 to 881       881/881
(100 %)
19 diff
(97.9 %id)
BF924617 nervous_tumor .a 2315 to 2617 303 to 1     Submitted on the opposite strand 303/303
(100 %)
2 diff
(99.4 %id)
BU848981 ovary, teratocarcinoma, cell line .a 2315 to 3037 77 to 810       736/978
(75 %)
22 diff
(97.8 %id)
BX396259 Placenta Cot 25-normalized .a 2319 to 3341 1016 to 1       1016/1019
(99 %)
11 diff
(99.0 %id)
TI_154135071   .a 2320 to 3157 904 to 77   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 828/942
(87 %)
28 diff
(97.1 %id)
BQ328069 kidney_tumor .a 2322 to 2585 1 to 264       264/264
(100 %)
9 diff
(96.6 %id)
BX381161 Placenta Cot 25-normalized .a 2327 to 3319 991 to 1       991/1002
(98 %)
12 diff
(98.9 %id)
BQ328070 kidney_tumor .a 2330 to 2541 1 to 212       212/212
(100 %)
2 diff
(99.1 %id)
TI_154135106   .a 2340 to 3149 880 to 78   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 803/953
(84 %)
10 diff
(99.0 %id)
TI_154115440   .a 2345 to 3157 890 to 91   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 800/941
(85 %)
7 diff
(99.3 %id)
BI011041 lung_normal .a 2352 to 2586 1 to 235       235/236
(99 %)
7 diff
(97.1 %id)
BI012007 lung_normal .a 2356 to 2462 7 to 110       102/110
(92 %)
6 diff
(94.6 %id)
BI012109 lung_normal .a 2356 to 2725 1 to 368       368/368
(100 %)
4 diff
(99.0 %id)
AA341323 Kidney .a 2358 to 2597 1 to 242       242/242
(100 %)
2 diff
(99.2 %id)
BI011053 lung_normal .a 2359 to 2904 9 to 553       545/553
(98 %)
7 diff
(98.8 %id)
BI012117 lung_normal .a 2359 to 2916 18 to 577       560/577
(97 %)
8 diff
(98.7 %id)
BI012137 lung_normal .a 2359 to 2598 15 to 252       238/252
(94 %)
6 diff
(97.7 %id)
BI010990 lung_normal .a 2361 to 2853 11 to 503       493/503
(98 %)
9 diff
(98.3 %id)
AI201829 Prostate .a 2374 to 2642 488 to 220       269/488
(55 %)
0 diff
(100 %id)
CF128852 Chondrosarcoma Lung Metastasis cell lines, lung .a 2374 to 2970 1 to 596       596/596
(100 %)
7 diff
(98.9 %id)
TI_154188987   .a 2374 to 3132 51 to 807       757/979
(77 %)
34 diff
(96.6 %id)
BI011964 lung_normal .a 2390 to 2952 18 to 576       559/577
(96 %)
10 diff
(98.3 %id)
BQ772919 Chondrosarcoma Cell line .a 2403 to 3157 772 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 754/756
(99 %)
2 diff
(99.8 %id)
BM907395 large cell carcinoma, lung .a 2412 to 3159 1 to 750       750/779
(96 %)
3 diff
(99.7 %id)
CF125033 Chondrosarcoma Lung Metastasis cell lines, lung .a 2414 to 3129 1 to 716       716/716
(100 %)
1 diff
(99.9 %id)
TI_154186431   .a 2414 to 3158 50 to 794       745/746
(99 %)
4 diff
(99.5 %id)
AA216064   .a 2431 to 2817 1 to 389       389/389
(100 %)
17 diff
(95.7 %id)
AL541460 placenta .a 2432 to 3248 869 to 52       818/978
(83 %)
8 diff
(99.2 %id)
CA449173 Chondrosarcoma, Left Pubic Bone .a 2432 to 3157 743 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 725/731
(99 %)
1 diff
(99.9 %id)
CA416323 Chondrosarcoma Cell line .a 2432 to 3157 742 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 724/725
(99 %)
2 diff
(99.8 %id)
BI016410 lung_tumor .a 2433 to 2626 29 to 222       196/222
(88 %)
6 diff
(97.3 %id)
TI_227714813   .a 2443 to 3354 956 to 63   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 894/990
(90 %)
21 diff
(97.9 %id)
FN103058 breast carcinoma .a 2448 to 2543 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
AI819401 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2448 to 3156 709 to 1       709/711
(99 %)
11 diff
(98.5 %id)
BM796672 Ascites, stomach .a 2450 to 2854 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
TI_154049992   .a 2454 to 3356 974 to 79       896/1090
(82 %)
12 diff
(98.9 %id)
BM706172 eye, lens .a 2456 to 3006 1 to 550   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 550/550
(100 %)
1 diff
(99.9 %id)
BI052621 placenta_normal .a 2465 to 2981 516 to 1       516/516
(100 %)
6 diff
(98.9 %id)
AW239166 lung, cell line .a 2467 to 2971 1 to 505       505/509
(99 %)
17 diff
(96.7 %id)
H48885 liver and spleen .a 2473 to 2851 1 to 384       384/393
(97 %)
10 diff
(97.5 %id)
CA440420 Chondrosarcoma, Left Pubic Bone .a 2480 to 3157 696 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 678/678
(100 %)
1 diff
(99.9 %id)
BU623896 cell lines, Enchondroma .a 2480 to 3157 695 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 677/677
(100 %)
2 diff
(99.8 %id)
BF992430 placenta_normal .a 2487 to 2831 343 to 1       343/343
(100 %)
29 diff
(91.6 %id)
H79059 liver and spleen .a 2491 to 2786 1 to 298       298/298
(100 %)
7 diff
(97.7 %id)
AA303875 aorta .a 2497 to 2899 1 to 407       407/407
(100 %)
9 diff
(97.8 %id)
BM689453 eye, Retina Foveal and Macular .a 2497 to 2744 12 to 259       248/259
(95 %)
6 diff
(97.7 %id)
BF340770 brain, glioblastoma with EGFR amplification .a 2498 to 3282 1 to 782       782/815
(95 %)
14 diff
(98.3 %id)
TI_154048212   .a 2500 to 3372 949 to 83   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 867/1023
(84 %)
18 diff
(98.3 %id)
BQ221363 melanotic melanoma, skin .a 2501 to 3353 1 to 863       863/867
(99 %)
26 diff
(97.1 %id)
BF991153 placenta_normal .a 2502 to 2831 330 to 1       330/330
(100 %)
0 diff
(100 %id)
TI_154135174   .a 2519 to 3372 921 to 76   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 846/935
(90 %)
17 diff
(98.2 %id)
BG167904 hypernephroma, cell line, Kidney .a 2521 to 3280 1 to 752       752/1074
(70 %)
17 diff
(98.5 %id)
CB119000 Liver .a 2523 to 2958 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
BQ020247 Chondrosarcoma, Left Pubic Bone .a 2535 to 3157 641 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 623/623
(100 %)
2 diff
(99.7 %id)
BQ000043 Fibrosarcoma .a 2539 to 3354 821 to 14   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 808/808
(100 %)
9 diff
(98.9 %id)
AI460178 colon .a 2543 to 3356 811 to 6       806/811
(99 %)
9 diff
(98.9 %id)
BF871574 lung_tumor .a 2546 to 2974 430 to 5     Submitted on the opposite strand 426/430
(99 %)
0 diff
(100 %id)
BQ331691 lung_tumor .a 2554 to 2960 8 to 415       408/415
(98 %)
6 diff
(98.6 %id)
BM549410 melanotic melanoma, skin .a 2554 to 3163 1 to 612       612/684
(89 %)
4 diff
(99.5 %id)
AL135543 melanoma (MeWo cell line) .a 2555 to 2722 1 to 167       169/167
(101 %)
4 diff
(97.7 %id)
BG945767 bladder_tumor .a 2560 to 2918 1 to 359       359/359
(100 %)
6 diff
(98.4 %id)
BP291359 lung .a 2570 to 3152 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CA441867 Chondrosarcoma, Left Pubic Bone .a 2570 to 3157 606 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 588/588
(100 %)
4 diff
(99.4 %id)
BF871569 lung_tumor .a 2574 to 2935 380 to 19     Submitted on the opposite strand 362/380
(95 %)
0 diff
(100 %id)
AW082670 pooled .a 2574 to 3158 589 to 5       585/589
(99 %)
0 diff
(100 %id)
BI012131 lung_normal .a 2593 to 3164 572 to 1       572/572
(100 %)
0 diff
(100 %id)
AW661966 2 pooled high-grade transitional celltumors, genitourinary tract .a 2602 to 3137 536 to 1       536/539
(99 %)
1 diff
(99.9 %id)
TI_154134995   .a 2602 to 3370 849 to 79   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 771/949
(81 %)
17 diff
(98.3 %id)
FN046069 breast carcinoma .a 2603 to 2682 1 to 80       80/81
(98 %)
3 diff
(96.3 %id)
TI_227713548   .a 2603 to 3370 827 to 60   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 768/1017
(75 %)
7 diff
(99.4 %id)
TI_154032842   .a 2606 to 3157 585 to 34   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 552/961
(57 %)
0 diff
(100 %id)
AA037799 uterus .a 2607 to 2835 1 to 231       231/231
(100 %)
3 diff
(98.8 %id)
TI_154135087   .a 2609 to 3370 836 to 79   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 758/949
(79 %)
11 diff
(98.9 %id)
BM993726 lung, Metastatic Chondrosarcoma .a 2610 to 3157 566 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 548/548
(100 %)
0 diff
(100 %id)
AW887751 ovary .a 2613 to 3061 452 to 1       452/452
(100 %)
22 diff
(95.2 %id)
BF792119 adrenal cortex carcinoma, cell line, adrenal gland .a 2620 to 3372 1 to 751   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 751/751
(100 %)
5 diff
(99.4 %id)
AA329013   .a 2621 to 2924 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
AA335346 epididymis .a 2622 to 2972 1 to 354       354/356
(99 %)
9 diff
(97.5 %id)
AI080302 senescent fibroblast .a 2623 to 3356 736 to 7       730/736
(99 %)
0 diff
(100 %id)
AA330812 embryo .a 2627 to 2930 1 to 304       304/304
(100 %)
1 diff
(99.7 %id)
AA345653 gall bladder .a 2632 to 2831 5 to 204       200/204
(98 %)
6 diff
(97.1 %id)
AA345203 gall bladder .a 2635 to 2845 1 to 211       211/211
(100 %)
0 diff
(100 %id)
AA345237 gall bladder .a 2635 to 2841 1 to 207       207/207
(100 %)
1 diff
(99.6 %id)
BI012035 lung_normal .a 2638 to 3170 555 to 23       533/555
(96 %)
0 diff
(100 %id)
BE206567 Kidney, renal cell adenocarcinoma .a 2642 to 3157 530 to 15   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 516/516
(100 %)
3 diff
(99.5 %id)
BI011941 lung_normal .a 2652 to 3164 1 to 513       513/513
(100 %)
1 diff
(99.9 %id)
BM547921 brain, hippocampus .a 2655 to 3356 15 to 716       702/720
(97 %)
2 diff
(99.8 %id)
BQ008963 Chondrosarcoma, Left Pelvis .a 2656 to 3349 707 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 695/695
(100 %)
3 diff
(99.6 %id)
BQ010120 Chondrosarcoma, Left Pubic Bone .a 2659 to 3349 709 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 691/691
(100 %)
3 diff
(99.6 %id)
BQ331649 lung_tumor .a 2662 to 3196 545 to 11       535/546
(97 %)
0 diff
(100 %id)
BQ003965 Chondrosarcoma, Left Pelvis .a 2662 to 3372 728 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 712/712
(100 %)
1 diff
(99.9 %id)
BI012054 lung_normal .a 2665 to 3171 519 to 13       507/519
(97 %)
0 diff
(100 %id)
AI871707 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2666 to 3137 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AI950952 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 2666 to 3137 472 to 1       472/472
(100 %)
4 diff
(99.2 %id)
AI984496 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2670 to 3372 714 to 12   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 703/703
(100 %)
24 diff
(96.6 %id)
TI_154126331   .a 2670 to 3356 747 to 61       687/1020
(67 %)
0 diff
(100 %id)
CA413685 Chondrosarcoma Grade II, Left Pelvis .a 2671 to 3356 697 to 12       686/697
(98 %)
0 diff
(100 %id)
CD364517 Alveolar Macrophage, lung .a 2671 to 3370 717 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 702/702
(100 %)
3 diff
(99.6 %id)
BQ019553 Chondrosarcoma, Left Pubic Bone .a 2674 to 3354 694 to 14   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 681/681
(100 %)
6 diff
(99.2 %id)
CD742754 Alveolar Macrophage, lung .a 2677 to 3354 696 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
BU684531 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2678 to 3349 689 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 671/671
(100 %)
1 diff
(99.9 %id)
BQ181683 Knee, Osteoarthritic Cartilage .a 2679 to 3372 711 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
CB242657 Human Lung Epithelial cells, lung .a 2679 to 3349 689 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 671/671
(100 %)
0 diff
(100 %id)
CA412839 Chondrosarcoma Grade II, Left Pelvis .a 2679 to 3370 711 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 693/693
(100 %)
2 diff
(99.8 %id)
CA413267 Chondrosarcoma Grade II, Left Pelvis .a 2679 to 3372 715 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 697/697
(100 %)
5 diff
(99.3 %id)
AA151261 uterus .a 2680 to 3019 1 to 346   fully sequenced,   346/346
(100 %)
3 diff
(99.2 %id)
AA362411   .a 2686 to 3004 1 to 319       319/319
(100 %)
0 diff
(100 %id)
AJ710113 heart .a 2695 to 3193 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CA392504 eye, RPE/choroid .a 2695 to 3348 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
H47231 liver and spleen .a 2696 to 3024 1 to 337       337/341
(98 %)
11 diff
(96.8 %id)
AA679754   .a 2699 to 3349 646 to 1       646/649
(99 %)
16 diff
(97.6 %id)
AI870163 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2702 to 3373 675 to 6       670/675
(99 %)
0 diff
(100 %id)
R07523 liver and spleen .a 2705 to 3050 1 to 363   fully sequenced,   363/363
(100 %)
15 diff
(95.9 %id)
AW305267 pooled .a 2705 to 3343 651 to 14   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 638/638
(100 %)
8 diff
(98.8 %id)
CX761732 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2706 to 3372 680 to 15   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 666/667
(99 %)
14 diff
(98.0 %id)
BM704065 eye, Retina Foveal and Macular .a 2706 to 3128 1 to 423   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 423/423
(100 %)
1 diff
(99.8 %id)
BM715231 eye, human retina .a 2706 to 3299 1 to 594       594/594
(100 %)
0 diff
(100 %id)
TI_153984980   .a 2706 to 3373 56 to 723       668/953
(70 %)
9 diff
(99.1 %id)
BQ182750 Knee, Osteoarthritic Cartilage .a 2707 to 3349 661 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
AA707559 liver and spleen .a 2708 to 3348 647 to 1       647/652
(99 %)
35 diff
(94.7 %id)
AW015421   .a 2711 to 3157 464 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
BM710125 eye, optic nerve .a 2711 to 3157 1 to 447       447/447
(100 %)
3 diff
(99.4 %id)
CD370873 Alveolar Macrophage, lung .a 2713 to 3372 679 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 661/661
(100 %)
1 diff
(99.9 %id)
BQ448281 Knee, Osteoarthritic Cartilage .a 2733 to 3372 657 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 641/641
(100 %)
4 diff
(99.4 %id)
CD365996 Alveolar Macrophage, lung .a 2735 to 3356 633 to 12       622/633
(98 %)
0 diff
(100 %id)
AA535403 invasive prostate tumor, Prostate .a 2736 to 3150 463 to 49   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 415/426
(97 %)
15 diff
(96.5 %id)
AI537280 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2737 to 3137 403 to 1       403/439
(91 %)
31 diff
(93.0 %id)
BF813569 colon_ins .a 2757 to 2948 198 to 8     Submitted on the opposite strand 191/198
(96 %)
0 diff
(100 %id)
AA706837 liver and spleen .a 2767 to 3343 576 to 1       576/576
(100 %)
6 diff
(99.0 %id)
AA643663 colon, colon tumor RER+ .a 2780 to 3361 582 to 1       582/582
(100 %)
27 diff
(95.4 %id)
BG035512 adenocarcinoma, cell line, Liver .a 2781 to 3403 1 to 623       623/1085
(57 %)
14 diff
(98.8 %id)
AI332816 lung .a 2793 to 3365 573 to 1       573/573
(100 %)
26 diff
(95.5 %id)
AW373119 breast .a 2795 to 3192 21 to 419       399/420
(95 %)
13 diff
(97.0 %id)
AW384636 head_neck .a 2795 to 3192 21 to 419       399/420
(95 %)
13 diff
(97.0 %id)
AU154062   .a 2800 to 3349 550 to 1       550/552
(99 %)
3 diff
(99.5 %id)
AW749509 breast .a 2803 to 3172 377 to 1       377/388
(97 %)
16 diff
(95.9 %id)
AW973687   .a 2803 to 3346 546 to 3     Submitted on the opposite strand 544/549
(99 %)
0 diff
(100 %id)
CV400219 head_neck .a 2803 to 3172 377 to 1     Submitted on the opposite strand 377/388
(97 %)
16 diff
(95.9 %id)
AI813650 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 2805 to 3356 566 to 14       553/566
(97 %)
0 diff
(100 %id)
AI186200 placenta .a 2808 to 3347 540 to 1       540/544
(99 %)
49 diff
(91.0 %id)
AA836930 Kidney, kidney tumor .a 2810 to 3354 543 to 1       543/543
(100 %)
7 diff
(98.8 %id)
AA669912 bone marrow stroma .a 2811 to 3366 549 to 1       549/552
(99 %)
30 diff
(94.6 %id)
BE208820 Kidney, renal cell adenocarcinoma .a 2814 to 3373 564 to 5       560/564
(99 %)
0 diff
(100 %id)
BE207859 Kidney, renal cell adenocarcinoma .a 2815 to 3373 563 to 5       559/563
(99 %)
0 diff
(100 %id)
BM982173 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2817 to 3349 545 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 533/535
(99 %)
2 diff
(99.7 %id)
CX781896 human embryonic stem cells .a 2820 to 3356 556 to 19       538/556
(96 %)
0 diff
(100 %id)
AI755128 bone marrow stroma .a 2828 to 3157 350 to 21   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 330/330
(100 %)
0 diff
(100 %id)
AA126718 uterus .a 2828 to 3350 526 to 1       526/534
(98 %)
4 diff
(99.3 %id)
AA126758 uterus .a 2828 to 3350 527 to 1       527/535
(98 %)
7 diff
(98.7 %id)
BG054809 brain, glioblastoma (pooled) .a 2828 to 3343 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
AA156916 uterus .a 2829 to 3341 1 to 510   fully sequenced,   510/510
(100 %)
59 diff
(88.5 %id)
AI807822 pooled .a 2831 to 3372 555 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 540/540
(100 %)
11 diff
(98.0 %id)
AI360666 adenocarcinoma, Pancreas .a 2835 to 3137 303 to 1       303/303
(100 %)
0 diff
(100 %id)
AA746146 Kidney .a 2849 to 3354 522 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 505/505
(100 %)
12 diff
(97.7 %id)
AI088348 uterus .a 2856 to 3349 506 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 494/494
(100 %)
1 diff
(99.8 %id)
AA594482 colon, colon tumor RER+ .a 2859 to 3349 489 to 1       489/518
(94 %)
7 diff
(98.7 %id)
AA853751 Bone, Hip .a 2861 to 3158 304 to 7       298/304
(98 %)
0 diff
(100 %id)
AA070846   .a 2863 to 3244 1 to 390       390/390
(100 %)
11 diff
(97.2 %id)
AA434492 ovarian tumor, ovary .a 2865 to 3157 1 to 292   fully sequenced,   292/292
(100 %)
1 diff
(99.7 %id)
BF941425 brain, glioblastoma (pooled) .a 2867 to 3343 479 to 1       479/479
(100 %)
18 diff
(96.3 %id)
AA156613 uterus .a 2868 to 3350 491 to 1   fully sequenced,   491/491
(100 %)
11 diff
(97.8 %id)
AI127564 uterus .a 2869 to 3370 501 to 1       501/501
(100 %)
6 diff
(98.9 %id)
AI373445 uterus .a 2869 to 3349 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
AA927277 squamous cell carcinoma from base of tongue, tongue .a 2874 to 3373 498 to 2       497/498
(99 %)
0 diff
(100 %id)
AA553717 breast .a 2876 to 3349 484 to 12   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 473/512
(92 %)
4 diff
(99.3 %id)
BX331669 Neuroblastoma Cot 10-normalized .a 2877 to 3151 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AI865617 normal prostate, Prostate .a 2878 to 3370 514 to 23   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 492/545
(90 %)
23 diff
(95.8 %id)
AA703600 liver and spleen .a 2887 to 3296 407 to 1       407/407
(100 %)
18 diff
(95.6 %id)
BF436004 pooled .a 2898 to 3156 259 to 1       259/259
(100 %)
0 diff
(100 %id)
BU789815 insulinoma, Pancreas .a 2905 to 3349 471 to 27   AAA Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
H97372 melanocyte .a 2910 to 3355 447 to 1       447/452
(98 %)
5 diff
(98.9 %id)
AA706867 liver and spleen .a 2911 to 3370 460 to 1       460/460
(100 %)
5 diff
(99.0 %id)
N29501 placenta .a 2914 to 3370 460 to 1       460/461
(99 %)
5 diff
(99.0 %id)
AA994798 breast .a 2914 to 3358 444 to 1       444/449
(98 %)
38 diff
(91.6 %id)
ES315120 occipital scalp hair, skin .a 2922 to 3093 1 to 171       171/171
(100 %)
1 diff
(99.5 %id)
BM988064 Bone, Subchondral Bone .a 2926 to 3150 243 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
CD299378 Blood vessels - aorta, basilar and artery .a 2941 to 3372 1 to 432       432/463
(93 %)
5 diff
(99.0 %id)
AI289271 2 pooled tumors (clear cell type), Kidney .a 2942 to 3373 434 to 3   tiling clone,   432/434
(99 %)
0 diff
(100 %id)
AI472244 pooled .a 2951 to 3349 415 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 399/399
(100 %)
0 diff
(100 %id)
AA551648 normal prostatic epithelial cells, Prostate .a 2953 to 3341 1 to 392       392/392
(100 %)
15 diff
(96.2 %id)
AI587050 adenocarcinoma, Pancreas .a 2954 to 3137 184 to 1       184/184
(100 %)
0 diff
(100 %id)
AI301838 2 pooled tumors (clear cell type), Kidney .a 2958 to 3373 431 to 16       416/431
(96 %)
0 diff
(100 %id)
BJ994458 hepatoblastoma .a 2959 to 3324 366 to 1       366/366
(100 %)
0 diff
(100 %id)
AA532429 normal prostatic epithelial cells, Prostate .a 2962 to 3266 1 to 305       305/305
(100 %)
12 diff
(96.1 %id)
AI061074   .a 2962 to 3360 400 to 2       399/400
(99 %)
0 diff
(100 %id)
AI989755 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 2962 to 3349 388 to 1       388/388
(100 %)
0 diff
(100 %id)
BQ375785 testis_normal .a 2964 to 3202 1 to 239       239/239
(100 %)
15 diff
(93.8 %id)
BU736942 eye, lens .a 2976 to 3349 392 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
AA149045 uterus .a 2989 to 3372 388 to 1   fully sequenced,   388/388
(100 %)
4 diff
(99.0 %id)
AA151083 uterus .a 2992 to 3354 1 to 366   fully sequenced,   366/366
(100 %)
6 diff
(98.4 %id)
DB487019 hypothalamus .a 3002 to 3429 1 to 426       426/426
(100 %)
1 diff
(99.8 %id)
H48886 liver and spleen .a 3009 to 3367 364 to 1       364/426
(85 %)
11 diff
(97.5 %id)
AA434397 ovarian tumor, ovary .a 3013 to 3158 146 to 1   fully sequenced,   146/146
(100 %)
0 diff
(100 %id)
H27321 breast .a 3019 to 3346 336 to 3       334/340
(98 %)
0 diff
(100 %id)
R07472 liver and spleen .a 3020 to 3351 344 to 1   fully sequenced,   344/344
(100 %)
10 diff
(97.1 %id)
D29504   .a 3036 to 3343 1 to 305       305/305
(100 %)
5 diff
(98.4 %id)
H61400 ovarian tumor, ovary .a 3041 to 3356 1 to 315   fully sequenced,   315/315
(100 %)
1 diff
(99.7 %id)
BI058673 placenta_normal .a 3047 to 3279 1 to 234       234/241
(97 %)
6 diff
(97.6 %id)
AI053721 ovary, papillary serous carcinoma .a 3052 to 3149 113 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 96/106
(90 %)
6 diff
(94.4 %id)
AI318620 early stage papillary serous carcinoma, ovary .a 3052 to 3349 14 to 309   AAA Submitted on the opposite strand 296/309
(95 %)
6 diff
(98.1 %id)
AI307408 early stage papillary serous carcinoma, ovary .a 3052 to 3349 31 to 326   AAA Submitted on the opposite strand 296/326
(90 %)
6 diff
(98.2 %id)
AI335376 invasive adenocarcinoma, lung .a 3052 to 3348 25 to 319   AAA Submitted on the opposite strand 295/319
(92 %)
6 diff
(98.2 %id)
BE139697 ovary, papillary serous carcinoma .a 3052 to 3147 13 to 106     Submitted on the opposite strand 94/106
(88 %)
6 diff
(94.4 %id)
AW301435 invasive adenocarcinoma, lung .a 3052 to 3156 25 to 127     Submitted on the opposite strand 103/127
(81 %)
6 diff
(95.3 %id)
AA493532 Prostate .a 3058 to 3372 1 to 315   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 315/315
(100 %)
7 diff
(97.8 %id)
AW894213 nervous_normal .a 3059 to 3276 14 to 228       215/228
(94 %)
6 diff
(97.4 %id)
AI053959 ovary, papillary serous carcinoma .a 3065 to 3147 83 to 1       83/94
(88 %)
0 diff
(100 %id)
AI284885 breast, invasive carcinoma .a 3065 to 3154 10 to 99       90/99
(90 %)
6 diff
(94.0 %id)
AI284904 breast, invasive carcinoma .a 3065 to 3155 10 to 100       91/100
(91 %)
6 diff
(94.0 %id)
AI287728 breast, invasive carcinoma .a 3065 to 3372 13 to 320   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 308/320
(96 %)
6 diff
(98.2 %id)
AI223783 borderline ovarian carcinoma, ovary .a 3065 to 3349 13 to 297   AAA Submitted on the opposite strand 285/297
(95 %)
6 diff
(98.0 %id)
AW302716 ovary, papillary serous carcinoma .a 3065 to 3154 13 to 102     Submitted on the opposite strand 90/102
(88 %)
6 diff
(94.2 %id)
BE139110 ovary, papillary serous carcinoma .a 3065 to 3154 13 to 102     Submitted on the opposite strand 90/102
(88 %)
6 diff
(94.2 %id)
BE139300 ovary, papillary serous carcinoma .a 3065 to 3155 13 to 103     Submitted on the opposite strand 91/103
(88 %)
6 diff
(94.2 %id)
BE139322 ovary, papillary serous carcinoma .a 3065 to 3156 13 to 104     Submitted on the opposite strand 92/104
(88 %)
6 diff
(94.3 %id)
BE138389 ovary, papillary serous carcinoma .a 3065 to 3365 13 to 312   AAA Submitted on the opposite strand 300/312
(96 %)
6 diff
(98.1 %id)
BE138405 ovary, papillary serous carcinoma .a 3065 to 3156 13 to 104     Submitted on the opposite strand 92/104
(88 %)
6 diff
(94.3 %id)
BE138670 invasive adenocarcinoma, lung .a 3065 to 3368 40 to 348     Submitted on the opposite strand 309/348
(88 %)
6 diff
(98.3 %id)
AW268241 invasive adenocarcinoma, lung .a 3065 to 3349 13 to 297   AAA Submitted on the opposite strand 285/297
(95 %)
6 diff
(98.0 %id)
AW269103 invasive adenocarcinoma, lung .a 3065 to 3370 13 to 318   AAA Submitted on the opposite strand 306/318
(96 %)
6 diff
(98.2 %id)
BF718631 epidermis, foreskin .a 3071 to 3371 302 to 2       301/302
(99 %)
0 diff
(100 %id)
H53108 liver and spleen .a 3078 to 3327 250 to 1       250/250
(100 %)
4 diff
(98.4 %id)
CD679415 eye, Trabecular meshwork .a 3092 to 3372 1 to 281   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 281/281
(100 %)
2 diff
(99.3 %id)
BP388885 pancreatic islet .a 3094 to 3360 1 to 267   AAA Submitted on the opposite strand 267/267
(100 %)
1 diff
(99.7 %id)
BU729973 eye, Retina Foveal and Macular .a 3098 to 3372 291 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 275/275
(100 %)
1 diff
(99.7 %id)
AW517622 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3103 to 3370 288 to 20   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 269/278
(96 %)
8 diff
(97.2 %id)
FN065139 breast carcinoma .a 3113 to 3163 1 to 51       51/52
(98 %)
1 diff
(98.1 %id)
H47232 liver and spleen .a 3121 to 3373 265 to 7       259/265
(97 %)
0 diff
(100 %id)
C02298   .a 3139 to 3349 1 to 211       211/211
(100 %)
0 diff
(100 %id)
AI972794 Prostate .a 3151 to 3333 183 to 1       183/183
(100 %)
9 diff
(95.1 %id)
BG054483 dorsal root ganglia .a 3154 to 3373 220 to 1       220/220
(100 %)
0 diff
(100 %id)
T29697 synovial membrane .a 3156 to 3469 1 to 314       314/314
(100 %)
0 diff
(100 %id)
AA150994 uterus .a 3172 to 3370 200 to 1   fully sequenced,   200/200
(100 %)
0 diff
(100 %id)
AI002272 Kidney, kidney tumor .a 3175 to 3353 179 to 1       179/194
(92 %)
8 diff
(95.9 %id)
R02361 liver and spleen .a 3176 to 3349 176 to 3       174/176
(98 %)
0 diff
(100 %id)
BM723865 eye, fetal eye .a 3182 to 3349 8 to 175   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 168/175
(96 %)
6 diff
(96.6 %id)
BM680031 eye, fetal eye .a 3221 to 3349 147 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 129/129
(100 %)
0 diff
(100 %id)
ES312069 frontal balding hair, skin .a 3227 to 3373 154 to 9     Submitted on the opposite strand 146/155
(94 %)
0 diff
(100 %id)
H62415 ovarian tumor, ovary .a 3246 to 3346 105 to 1   fully sequenced,   105/105
(100 %)
0 diff
(100 %id)
H97373.
matches multiple genes
melanocyte .a 3272 to 3351 83 to 4     also hits gene CELSR2 80/83
(96 %)
0 diff
(100 %id)
AL598556   .b 1 to 470 1 to 470   tiling clone,   470/470
(100 %)
2 diff
(99.6 %id)
DB046581 testis .b 147 to 721 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
AU139921 placenta .b 630 to 1232 2 to 604   tiling clone, capped   603/603
(100 %)
4 diff
(99.4 %id)
AU137194 placenta .b 887 to 1599 2 to 714   tiling clone, capped   713/719
(99 %)
14 diff
(98.1 %id)
DA872698 Prostate .b 912 to 1473 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DB380512 placenta .b 2210 to 2671 462 to 1   tiling clone,   462/465
(99 %)
26 diff
(94.5 %id)
DB376279 placenta .b 2360 to 2886 522 to 1   tiling clone,   522/524
(99 %)
23 diff
(95.7 %id)
BG765510 melanotic melanoma, high MDR (cell line), skin .c 1 to 890 1 to 888   tiling clone,   888/890
(99 %)
15 diff
(98.4 %id)
BQ674133 epidermoid carcinoma, cell line, salivary gland .c 275 to 648 25 to 403       379/819
(46 %)
15 diff
(98.2 %id)
BU175024 epidermoid carcinoma, cell line, salivary gland .c 277 to 761 1 to 486       486/1111
(43 %)
14 diff
(98.8 %id)
BQ673891 epidermoid carcinoma, cell line, salivary gland .c 277 to 1141 1 to 871       871/871
(100 %)
12 diff
(98.7 %id)
BU197234 epidermoid carcinoma, cell line, salivary gland .c 277 to 1052 1 to 788       788/901
(87 %)
21 diff
(97.7 %id)
BQ668901 epidermoid carcinoma, cell line, salivary gland .c 277 to 634 1 to 358       358/358
(100 %)
0 diff
(100 %id)
BQ671257 epidermoid carcinoma, cell line, salivary gland .c 277 to 1211 1 to 938       938/950
(98 %)
31 diff
(96.8 %id)
AK309551   .c 279 to 1442 1 to 1164   tiling clone,   1164/1164
(100 %)
0 diff
(100 %id)
DA602691   .c 280 to 841 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA451081 tongue, tumor tissue .d -9 to 545 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA458599 tongue, tumor tissue .d 1 to 435 6 to 440   capped   439/584
(75 %)
1 diff
(99.9 %id)
DB137667 thymus .d 1 to 469 6 to 474   capped   473/473
(100 %)
4 diff
(99.2 %id)
DB157795 thymus .d 1 to 570 6 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA402031 thalamus .d 1 to 549 5 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA444785 tongue, tumor tissue .d 1 to 571 5 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA447452 tongue, tumor tissue .d 1 to 542 5 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA450089 tongue, tumor tissue .d 1 to 573 5 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA905746   .d 1 to 570 5 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DB111219 thymus .d 1 to 580 5 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA442667 tongue, tumor tissue .d 1 to 580 3 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
DA878246 Prostate .d 1 to 567 3 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA934994 Spleen .d 1 to 511 2 to 512   capped   511/511
(100 %)
2 diff
(99.7 %id)
DA434719 tongue, tumor tissue .d 3 to 511 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
DA439191 tongue, tumor tissue .d 3 to 522 23 to 542   capped   520/520
(100 %)
0 diff
(100 %id)
DA446494 tongue, tumor tissue .d 3 to 577 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA451608 tongue, tumor tissue .d 3 to 566 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA451682 tongue, tumor tissue .d 3 to 564 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA457344 tongue, tumor tissue .d 3 to 565 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA460951 tongue, tumor tissue .d 3 to 561 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA461886 tongue, tumor tissue .d 3 to 296 2 to 297   capped   296/296
(100 %)
3 diff
(99.0 %id)
DA707815   .d 3 to 573 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA905373   .d 3 to 551 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB144521 thymus .d 3 to 534 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA903878   .d 6 to 560 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA992646 synovial membrane tissue from rheumatioidarthritis .d 6 to 541 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB093137 testis .d 6 to 555 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA950326 Spleen .d 8 to 579 2 to 573   capped   572/572
(100 %)
5 diff
(99.2 %id)
DA991054 synovial membrane tissue from rheumatioidarthritis .d 9 to 552 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA098721 cerebellum .d 10 to 565 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA435074 tongue, tumor tissue .d 10 to 579 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA442004 tongue, tumor tissue .d 10 to 610 2 to 602   tiling clone, capped   601/601
(100 %)
1 diff
(99.9 %id)
DA447351 tongue, tumor tissue .d 10 to 593 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA449787 tongue, tumor tissue .d 10 to 573 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB141741 thymus .d 10 to 564 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB287099 uterus .d 10 to 580 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA445250 tongue, tumor tissue .d 15 to 569 8 to 562   capped   555/555
(100 %)
0 diff
(100 %id)
TI_57201221   .d 15 to 813 28 to 827       800/827
(96 %)
18 diff
(97.9 %id)
BI823966 pooled brain, lung, testis .d 17 to 813 1 to 798   tiling clone,   798/798
(100 %)
12 diff
(98.5 %id)
CO249258 Chondrosarcoma Lung Metastasis cell lines, lung .d 17 to 689 8 to 672   tiling clone,   665/764
(87 %)
22 diff
(97.2 %id)
BG390270 embryonal carcinoma, cell line, testis .d 21 to 787 1 to 773       773/778
(99 %)
11 diff
(98.6 %id)
CN268799 embryonic stem cells, cell lines H1, H7, andH9 .d 25 to 281 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
BG248602 adenocarcinoma cell line, colon .d 25 to 853 1 to 815       815/871
(93 %)
11 diff
(98.8 %id)
BG468153 adenocarcinoma cell line, colon .d 25 to 614 1 to 590       590/593
(99 %)
3 diff
(99.5 %id)
BG762278 melanotic melanoma, high MDR (cell line), skin .d 678 to 1197 1 to 520       520/520
(100 %)
4 diff
(99.3 %id)
BG763377 melanotic melanoma, high MDR (cell line), skin .d 678 to 1421 1 to 744   tiling clone,   744/744
(100 %)
6 diff
(99.2 %id)
BG768043 melanotic melanoma, high MDR (cell line), skin .d 678 to 1472 1 to 793   tiling clone,   793/793
(100 %)
10 diff
(98.8 %id)
BG764439 melanotic melanoma, high MDR (cell line), skin .d 679 to 1387 1 to 711       711/711
(100 %)
17 diff
(97.7 %id)
DA647472   .e 1 to 794 2 to 797 Q108X R196X C202X F215L F217S ... tiling clone, capped   796/816
(97 %)
11 diff
(98.7 %id)
AK091595 brain .f-u 1 to 3583 2 to 3584 R87* tiling clone, available from FLJ,   3584/3584
(100 %)
5 diff
(99.9 %id)
AX747081   .f-u 1 to 3583 2 to 3584 R87*     3584/3584
(100 %)
5 diff
(99.9 %id)
DA515435 brain .f-u 1 to 555 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BF879140 lung_tumor .f-u 840 to 1146 16 to 323   tiling clone,   308/344
(89 %)
6 diff
(98.3 %id)
BI025181 marrow .f-u 1292 to 1591 302 to 1   tiling clone,   302/317
(95 %)
12 diff
(96.3 %id)
DA930451 small intestine .f-u 2157 to 2756 2 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
DB316783 brain .f-u 3014 to 3583 571 to 1       571/571
(100 %)
2 diff
(99.7 %id)
ES310235 scalp interfollicular dermis, skin .f-u 3053 to 3603 556 to 2   tiling clone, Submitted on the opposite strand 555/558
(99 %)
0 diff
(100 %id)
DA067331 cerebellum .g 1 to 576 2 to 577 V119A tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DA962699 stomach .h 1 to 511 2 to 513 A94C S95I N96Q Q97P M98D ... tiling clone, capped   512/512
(100 %)
3 diff
(99.5 %id)
BP223071   .i 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
BM469873 melanotic melanoma, skin .j 1 to 444 1 to 445 C131R S134I G136P Y137L L138P ... tiling clone,   445/1224
(36 %)
11 diff
(99.2 %id)
DB043912 testis .k 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
BQ310299 breast .l 1 to 492 13 to 503       491/503
(97 %)
6 diff
(98.9 %id)
BF964221 nervous_normal .l 5 to 185 182 to 1   tiling clone,   182/182
(100 %)
2 diff
(99.0 %id)
BQ310298 breast .l 6 to 492 1 to 485       485/485
(100 %)
6 diff
(98.8 %id)
BQ310227 breast .l 23 to 492 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
AK054968 cerebellum .l 42 to 2269 1 to 2228 T89A tiling clone, available from FLJ,   2228/2232
(99 %)
8 diff
(99.7 %id)
DA060253 cerebellum .l 43 to 597 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
CD245207 White Matter .l 222 to 832 20 to 637   tiling clone,   618/944
(65 %)
21 diff
(97.8 %id)
DA590280 lung .l 236 to 792 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BI036059 nervous_tumor .l 716 to 1132 417 to 1   tiling clone,   417/417
(100 %)
3 diff
(99.3 %id)
BM710288 eye, RPE and Choroid .l 1161 to 1621 1 to 461 exact     461/461
(100 %)
0 diff
(100 %id)
DA567591   .l 1164 to 1708 2 to 546 exact capped   545/545
(100 %)
0 diff
(100 %id)
AA479580 ovarian tumor, ovary .l 1181 to 1687 10 to 514 E62I F63X fully sequenced,   505/514
(98 %)
11 diff
(97.9 %id)
AA481695 ovarian tumor, ovary .l 1186 to 1529 14 to 356   fully sequenced,   343/356
(96 %)
7 diff
(98.1 %id)
AW673578 cervix .l 1186 to 1751 9 to 574 exact tiling clone, fully sequenced,   566/574
(98 %)
8 diff
(98.7 %id)
AA291790 ovarian tumor, ovary .l 1187 to 1764 1 to 568 N25E T26P N28T A29P M30*     568/568
(100 %)
16 diff
(97.2 %id)
BM045700 carcinoma, cell line, Prostate .l 1198 to 2047 1 to 844 F99S N100Y K101N S102G Y103T ...     844/845
(99 %)
10 diff
(98.9 %id)
AA481459 ovarian tumor, ovary .l 1489 to 2052 565 to 1   fully sequenced,   565/565
(100 %)
2 diff
(99.7 %id)
AA477417 ovarian tumor, ovary .l 1657 to 2054 396 to 1   fully sequenced,   396/396
(100 %)
3 diff
(99.3 %id)
BQ277609 ovary, teratocarcinoma, cell line .l 1668 to 2525 953 to 80     Submitted on the opposite strand 874/1067
(81 %)
0 diff
(100 %id)
BF569578 Kidney, renal carcinoma (ascites) .l 1708 to 2405 1 to 696       696/697
(99 %)
10 diff
(98.6 %id)
BM664231 eye, RPE and Choroid .l 1721 to 2269 566 to 18       549/566
(96 %)
0 diff
(100 %id)
DB296942 cerebellum .l 1724 to 2269 550 to 5       546/550
(99 %)
0 diff
(100 %id)
AW731726 cervix .l 1731 to 2033 303 to 1   fully sequenced,   303/303
(100 %)
0 diff
(100 %id)
CN265303 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 1757 to 2483 8 to 735   tiling clone,   728/735
(99 %)
6 diff
(99.2 %id)
BG707765 brain, hypothalamus .l 1893 to 2601 1 to 719       719/719
(100 %)
10 diff
(98.7 %id)
BG753440 eye, normal pigmented retinal epithelium .l 1907 to 2522 1 to 614       614/982
(62 %)
9 diff
(99.1 %id)
BX095583 liver and spleen .l 2007 to 2775 1 to 768   tiling clone,   768/768
(100 %)
1 diff
(99.9 %id)
F07983 brain, total brain .l 2014 to 2331 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BF351113 head_neck .l 2421 to 2756 352 to 2       351/358
(98 %)
0 diff
(100 %id)
BF816700 colon_ins .l 2449 to 2982 573 to 27     Submitted on the opposite strand 547/585
(93 %)
0 diff
(100 %id)
CN289008 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 2517 to 3229 1 to 713       713/713
(100 %)
6 diff
(99.2 %id)
BF570064 Kidney, renal carcinoma (ascites) .l 2519 to 3214 699 to 1       699/991
(70 %)
14 diff
(98.6 %id)
AL048423 uterus .l 2533 to 3266 770 to 28   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 743/744
(99 %)
24 diff
(96.8 %id)
BQ007769 Chondrosarcoma, Left Pelvis .l 2537 to 3266 742 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 727/731
(99 %)
3 diff
(99.6 %id)
BQ015187 Chondrosarcoma, Left Pubic Bone .l 2542 to 3266 737 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 722/722
(100 %)
4 diff
(99.5 %id)
TI_157611244   .l 2644 to 3269 719 to 93       627/720
(87 %)
0 diff
(100 %id)
AW300562 Kidney .l 2730 to 3265 540 to 5       536/540
(99 %)
0 diff
(100 %id)
BF431597 Kidney .l 2735 to 3264 530 to 1       530/530
(100 %)
3 diff
(99.5 %id)
AI589197 Kidney .l 2794 to 3269 479 to 4   tiling clone,   476/479
(99 %)
0 diff
(100 %id)
DB556348 hypothalamus .l 2842 to 3266 1 to 425     Submitted on the opposite strand 425/425
(100 %)
0 diff
(100 %id)
AI269381 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 2878 to 3264 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI247496 liver and spleen .l 2905 to 3268 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AA947556 ovary .l 2985 to 3269 287 to 3       285/289
(98 %)
0 diff
(100 %id)
Z41056 brain, total brain .l 3049 to 3266 218 to 1       218/218
(100 %)
1 diff
(99.6 %id)
DA701664   .m 1 to 548 2 to 551   tiling clone, capped   550/550
(100 %)
5 diff
(99.1 %id)
DA931979 Spleen .m 3 to 549 2 to 548   tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
BP238458 Liver .m 7 to 624 1 to 618 P29T tiling clone,   618/618
(100 %)
5 diff
(99.2 %id)
DA145129 amygdala .n-u 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
CN370284 embryonic stem cells, cell lines H1, H7, andH9 .o-u 1 to 213 1 to 213 exact tiling clone,   213/213
(100 %)
0 diff
(100 %id)
AW025587 Kidney .o-u 44 to 321 278 to 1   tiling clone,   278/278
(100 %)
0 diff
(100 %id)
TI_151742810   Gene ITGB5, variant not shown       AAA This clone was ignored    
TI_153960052   Gene ITGB5, variant not shown         This clone was ignored    
BF868688 lung_tumor Gene ITGB5, variant not shown         Submitted on the opposite strand    
BF868955 lung_tumor Gene ITGB5, variant not shown         Submitted on the opposite strand    
AK130168   Gene ITGB5, variant not shown       available from FLJ, Suspected internal deletion, suspected internal deletion, this clone was ignored    
M35011   Gene ITGB5, variant not shown       AAA This clone was ignored    
X53002 thymic epithelium Gene ITGB5, variant not shown         Suspected internal deletion, this clone was ignored    
AA180072   Gene ITGB5, variant not shown         Submitted on the opposite strand    
AA180344   Gene ITGB5, variant not shown         Submitted on the opposite strand    
CX166380 human embryonic stem cells differentiated toan early endodermal cell type Gene ITGB5, variant not shown       AAA Submitted on the opposite strand    
TI_149297037   Gene ITGB5, variant not shown       AAA This clone was ignored    
TI_149298075   Gene ITGB5, variant not shown       AAA This clone was ignored    
TI_154047652   Gene ITGB5, variant not shown       AAA This clone was ignored    
TI_154101398   Gene ITGB5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_154196039   Gene ITGB5, variant not shown         This clone was ignored    
TI_159723245   Gene ITGB5, variant not shown       AAA This clone was ignored    
TI_227714305   Gene ITGB5, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l, .m, .n-u, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI